All articlesScience

Betahistine for Meniere's: How It Is Used, What the Trials Show, and Side Effects

Betahistine for Meniere's is a daily tablet meant to make attacks less frequent, and it is widely prescribed in the UK. But the trials have not shown that it works better than a placebo. The 2023 Cochrane review found 7 trials with 548 people, and rated all of the evidence very low certainty.

That does not mean it cannot help you. It means the studies are too small or too flawed to say. This post covers what betahistine is, what the trials and guidelines say, the side effects, and how to tell whether it is doing anything for you.

Not medical advice. This is a summary of public sources, not a recommendation to start, stop or change any medicine. The NHS says not to stop betahistine without talking to your doctor. Seek urgent care for sudden hearing loss in one ear, or for vertigo with a severe headache, double vision, slurred speech, weakness or numbness.
Betahistine for Meniere's at a glanceHow it is used: a daily tablet to prevent attacks, not to stop one. Trial evidence: the 2023 Cochrane review found 7 trials with 548 people, all very low certainty. Largest trial, BEMED: 221 people over 9 months, no better than placebo. Where it is prescribed: common in the UK, not licensed by the FDA in the US.Betahistine for Meniere's at a glanceWidely prescribed, weakly supported by trialsHow it is usedDaily tablet to preventattacks, not to stop oneTrial evidenceCochrane 2023: 7 trials,548 people, very low certaintyLargest trial (BEMED)221 people, 9 months:no better than placeboWhere it is prescribedCommon in the UK;not FDA-licensed in the US
Betahistine for Meniere's in four facts, from the NHS, the 2023 Cochrane review of oral medicines, the BEMED trial (BMJ 2016) and the AAO-HNS 2020 guideline.

What betahistine is and how it is thought to work

Betahistine is a prescription medicine, often sold as Serc. The NHS says it treats Meniere's symptoms such as vertigo, tinnitus, hearing loss and nausea, and reduces how often they happen.

Nobody is sure how it works. The Cochrane review describes it as acting on histamine receptors. It is thought to increase blood flow in the inner ear, which may affect the fluid pressure there. It may also calm the balance nerve directly.

It is a maintenance medicine. The AAO-HNS 2020 guideline lists it, with diuretics, as something taken over time to reduce or prevent attacks. It is not meant to stop an attack that has already started. For that, see what to do during a Meniere's attack.

Does betahistine work for Meniere's? What the trials show

The short answer is that nobody knows yet. Three bodies of evidence point the same way.

  • Cochrane 2023. The review of oral medicines for Meniere's found 7 betahistine trials (548 people). Its plain-language summary says: "It is unclear whether betahistine has an effect on vertigo symptoms. It is also unclear whether it causes any harm."
  • BEMED, the largest trial. In BEMED, 221 adults at 14 German centres took placebo or one of two doses of betahistine for nine months. Attack numbers did not differ between the groups (P = 0.759).
  • The earlier Cochrane review. The older review (7 trials, 243 people) found that none of the trials showed an effect on hearing loss. It said improvements in vertigo "may have been caused by bias in the methods".

The Cochrane review could report "vertigo improved" for only two time points, each from a single small trial:

Vertigo improved: betahistine vs placeboAt 6 to 12 months, in one trial of 70 people, 68.6% improved on betahistine and 45.7% on placebo. After more than 12 months, in one trial of 62 people, 93.3% improved on betahistine and 84.4% on placebo.Vertigo improved: betahistine vs placeboMost people on placebo improved too6 to 12 months1 trial, 70 people68.6% betahistine45.7% placeboOver 12 months1 trial, 62 people93.3% betahistine84.4% placebo
Share of people whose vertigo improved, betahistine vs placebo, in the two single trials the 2023 Cochrane review could report for this outcome. Neither difference was statistically clear, and the review rated the evidence very low certainty. Webster et al., Cochrane CD015171.

More people improved on betahistine in both trials, but the gap was not statistically clear in either. On how often attacks happened, the results pointed in different directions: about 1.9 fewer attacks a month with betahistine at 3 to 6 months, and 0.63 more at 6 to 12 months. All of it is very low certainty.

Why so many people feel better on it anyway

BEMED trial: attacks fell in every groupThree lines for placebo, low-dose and high-dose betahistine all fall over nine months and end close together.Attacks went down in every groupIncluding the group that took a placebomorefewermonth 0month 9PlaceboBetahistine, low doseBetahistine, high dose
Schematic of the shape of the result, not the published curves. In the BEMED trial (221 people, 9 months of treatment), attack incidence did not differ between placebo, low-dose and high-dose betahistine (P = 0.759). Adrion et al., BMJ 2016;352:h6816.

In BEMED, attacks fell steadily in every group, including placebo. The authors note that without a group given no treatment at all, they could not separate a placebo effect from the natural ups and downs of the disease.

That matters for anyone judging betahistine by how they feel. People often start a new medicine during a bad spell, and bad spells often ease on their own. The post on what Meniere's trials actually show explains why placebo groups in Meniere's trials do so well.

What the guidelines say

  • US (AAO-HNS 2020). The guideline says clinicians may offer diuretics and/or betahistine for maintenance therapy, and grades this an "option".
  • US availability. The Cochrane review notes that betahistine is not licensed by the FDA, so it is used much less in the US. A 2021 ENTtoday review says it is unavailable there for that reason.
  • UK, for tinnitus. NICE's 2020 tinnitus guideline says "do not offer betahistine to treat tinnitus", as Tinnitus UK reports. That is about tinnitus alone, not Meniere's. If ringing in one ear is your main symptom, see ringing in one ear only.

Prescribing has not followed the trials. A 2023 study of prescriptions in England found about 11.3 million tablets a month before BEMED was published and about 11.1 million a month after. The authors concluded that BEMED "made no difference to prescribing practice."

Side effects and who it may not suit

The NHS lists feeling sick, indigestion and headaches as common side effects. A serious allergic reaction (anaphylaxis) is rare. The Cochrane review also lists headache, stomach upset and sleep problems, with very low certainty.

The NHS says it may not be suitable if you:

  • have had an allergic reaction or other serious side effect from betahistine
  • have low blood pressure
  • have or have had a stomach ulcer
  • have asthma
  • are pregnant or breastfeeding

Tell your doctor about any other conditions and medicines before you take it.

Questions to ask your ENT about betahistine

If betahistine has been offered, or you already take it, these questions help you and your doctor agree on what "working" means:

  • What change would tell us it is helping: fewer attacks, shorter ones, or milder ones?
  • How long should I take it before we judge it?
  • What should I record in the meantime?
  • If it does not help, what is the next step?
  • Are any of my other conditions or medicines a concern with it?

The ENT visit checklist covers what else to bring, including a list of treatments you have tried.

How to tell whether it is helping you

Trials cannot answer this for you, but a steady record can help. The idea is the same as in the caffeine and alcohol experiment: know your normal, change one thing, and give it long enough.

  • Before: log at least a few weeks of attacks if you can, so there is a baseline to compare against.
  • During: record each attack's date, length and severity, plus daily ringing, fullness and muffled hearing.
  • Keep other things steady: avoid starting a new diet or another treatment in the same weeks, or you will not know which one mattered.
  • Note the noise: colds, stress, poor sleep and travel, which can move symptoms on their own.
  • Remember the waves: Meniere's quiets down by itself at times, so one good month is a first look, not proof.

The printable symptom diary works for this on paper.

Common questions

How long does betahistine take to work?

The NHS says you may need to take it for some time before symptoms get better, but gives no set timeframe. BEMED measured its main result over months 7 to 9 of treatment.

Does betahistine help tinnitus?

The older Cochrane review found that one well-run trial of 35 people showed no effect on tinnitus compared with placebo. NICE advises against offering it for tinnitus alone.

Can I get betahistine in the US?

It is not licensed by the FDA, so it is used much less in the US. Ask your ENT what they can offer instead; the low-sodium diet guide covers one of the lifestyle steps often discussed alongside medicines.

Can I stop taking betahistine?

The NHS says not to stop without talking to your doctor, because your condition may get worse. Bring your symptom record to that conversation.

The bottom line

Betahistine is widely prescribed for Meniere's, and the NHS lists only a few common side effects. But the largest trial found it did no better than placebo, and Cochrane rates all the evidence very low certainty. If you take it, agree with your ENT on what would count as working, and keep a record that can answer that question.

Sources: Webster KE et al., Systemic pharmacological interventions for Ménière's disease, Cochrane Database of Systematic Reviews (2023, CD015171); Cochrane, Betahistine for Ménière's disease or syndrome, Cochrane Database of Systematic Reviews (CD001873); Adrion C et al., Efficacy and safety of betahistine treatment in patients with Meniere's disease (BEMED), BMJ (2016); Basura GJ et al., Clinical Practice Guideline: Ménière's Disease, Otolaryngology–Head and Neck Surgery (2020); Sutton L, Ghedia R, Harcourt J, Betahistine prescribing practices in England, Otology & Neurotology (2023); NHS, Betahistine; Tinnitus UK, Betahistine; ENTtoday, Is betahistine effective in the treatment of Ménière's disease?, (2021). Always confirm specifics with a clinician familiar with your case.